hum.glp 1 Flatter Me Fiber GLP-1 Booster 𝗜𝘀 𝘁𝗵𝗶𝘀 𝘁𝗵𝗶𝗻𝗴 𝗼𝗻? 🎙

AstraZeneca, Novo Nordisk A/S, Eli Lilly and Company, Sanofi and Hypera S.A

Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.

Learn How Semaglutide GLP-1 Compares to Ozempic, Including Key Differences, Uses, and What Patients Should Know at Noor Medical Spa.

Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models.I've been reporting on this space in my #Trends report since March 2024two years ago (Navigating Obesity Care in the Digital Age)

In this review, we summarize the state-of-the-art evidence regarding the epidemiology and pathophysiology of diabetic HFpEF, and the landscape of the novel antidiabetic drugs in the treatment of diabetic HFpEF, as well as discuss the relevant mechanisms, aiming to broaden the understanding of diabetic HFpEF and gain new insight into the treatment of this disease

Not intended for use if you are pregnant or nursing